Form 8-K - Current report:
SEC Accession No. 0001193125-21-160502
Filing Date
2021-05-13
Accepted
2021-05-13 16:15:29
Documents
3
Period of Report
2021-05-13
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d120414d8k.htm 8-K 17395
2 EX-99.1 d120414dex991.htm EX-99.1 34718
3 GRAPHIC g120414ex99_1.jpg GRAPHIC 3364
  Complete submission text file 0001193125-21-160502.txt   58041
Mailing Address 4224 CAMPUS POINT COURT SUITE 210 SAN DIEGO CA 92121
Business Address 4224 CAMPUS POINT COURT SUITE 210 SAN DIEGO CA 92121 858-202-6300
Regulus Therapeutics Inc. (Filer) CIK: 0001505512 (see all company filings)

IRS No.: 264738379 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35670 | Film No.: 21919819
SIC: 2834 Pharmaceutical Preparations